William Meury
Director/Board Member bei SYNDAX PHARMACEUTICALS, INC.
Vermögen: 1 Mio $ am 31.03.2024
Profil
William J.
Meury is currently the Chief Executive Officer & Director at Anthos Therapeutics, Inc. He is also the Chairman at Crown Laboratories, Inc., Director at The Jed Foundation, Director at Allergan Foundation, and Director at International Council of Ophthalmology Foundation.
In addition, he serves as an Independent Director at Syndax Pharmaceuticals, Inc. and as a Senior Operating Advisor at Hildred Capital Management LLC.
Previously, Mr. Meury held the positions of President, Chief Executive Officer & Director at Karuna Therapeutics, Inc. from 2023 to 2024.
He was the Executive Vice President-Sales & Marketing at Forest Laboratories, Inc. from 1993 to 2014.
He also served as the Chief Commercial Officer & Executive VP at Allergan Ltd.
(Ireland) from 2014 to 2020, and as the Senior Vice President-Sales at Forest Pharmaceuticals, Inc. from 1993 to 2014.
Mr. Meury obtained his undergraduate degree from the University of Maryland.
Bekannte Unternehmensbeteiligungen
| Unternehmen | Datum | Anzahl der Aktien | Bewertung | Datum der Bewertung |
|---|---|---|---|---|
| 08.03.2024 | 48 000 ( 0,06% ) | 1 Mio $ | 31.03.2024 |
Aktive Positionen von William Meury
| Unternehmen | Position | Beginn |
|---|---|---|
| SYNDAX PHARMACEUTICALS, INC. | Director/Board Member | 25.09.2018 |
The Jed Foundation
 The Jed Foundation Miscellaneous Commercial ServicesCommercial Services The Jed Foundation exists to protect emotional health and prevent suicide for nation's teens and young adults. It develops expert resources and create partnerships. The firm educates and equip students, families and communities. The company was founded in 2000 and is headquartered in New York, NY. | Director/Board Member | - |
| International Council of Ophthalmology Foundation | Director/Board Member | - |
| Allergan Foundation | Director/Board Member | - |
Crown Laboratories, Inc.
 Crown Laboratories, Inc. Pharmaceuticals: OtherHealth Technology Crown Laboratories, Inc. provides pharmaceutical and consumer products. Its products include aesthetics, beauty, therapeutic and prescription products. The firm offers contract development, manufacturing, production and packaging servicers. The company was founded by Don Kilday and Jeff Bedard in November 2000 and is headquartered in Johnson City, TN. | Chairman | - |
Hildred Capital Management LLC
 Hildred Capital Management LLC Investment ManagersFinance Hildred Capital Management LLC (Hildred Capital) is a private equity firm founded in 2014 by David Solomon and Andrew Goldman. The firm is headquartered in New York. | Consultant / Advisor | - |
Anthos Therapeutics, Inc.
 Anthos Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Anthos Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops and commercializes innovative therapies for high-risk cardiovascular patients. It offers MAA868, an antibody directed at Factor XI and XIa, key components of the intrinsic coagulation pathway. The company was founded by Paris Panayiotopoulos, Ari Brettman and Jonathan E. Freeman in 2018 and is headquartered in Cambridge, MA. | Chief Executive Officer | 22.04.2024 |
Ehemalige bekannte Positionen von William Meury
| Unternehmen | Position | Ende |
|---|---|---|
| KARA THER | Chief Executive Officer | 18.03.2024 |
| ALLERGAN PLC | Corporate Officer/Principal | 08.05.2020 |
| ░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░ ░ ░░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░ ░░░░░░ ░░░░░░░░ | - |
Ausbildung von William Meury
| University of Maryland | Undergraduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
| Börsennotierte Unternehmen | 1 |
|---|---|
| SYNDAX PHARMACEUTICALS, INC. | Health Technology |
| Private Unternehmen | 10 |
|---|---|
Crown Laboratories, Inc.
Crown Laboratories, Inc. Pharmaceuticals: OtherHealth Technology Crown Laboratories, Inc. provides pharmaceutical and consumer products. Its products include aesthetics, beauty, therapeutic and prescription products. The firm offers contract development, manufacturing, production and packaging servicers. The company was founded by Don Kilday and Jeff Bedard in November 2000 and is headquartered in Johnson City, TN. | Health Technology |
Forest Laboratories, Inc.
 Forest Laboratories, Inc. Pharmaceuticals: MajorHealth Technology Forest Laboratories, Inc. is engaged in the development, manufacture, and sale of branded forms of drug products. Its products include Bystolic, which is used to decrease heart rate and myocardial contractility; Daliresp, which is used to reduce the risk of chronic obstructive pulmonary disease exacerbation; Linzess, which is used in the treatment of irritable bowel syndrome with constipation and chronic idiopathic constipation; and Namenda, which is used in the treatment of moderate to severe dementia. The company was founded in 1954 and is headquartered in New York, NY. | Health Technology |
Forest Pharmaceuticals, Inc.
 Forest Pharmaceuticals, Inc. Forest ProductsNon-Energy Minerals Forest Pharmaceuticals, Inc. manufactures, distributes, and sells forest-branded prescription products in the United States and Puerto Rico. The company is headquartered in St. Louis, MO. | Non-Energy Minerals |
| International Council of Ophthalmology Foundation | |
The Jed Foundation
The Jed Foundation Miscellaneous Commercial ServicesCommercial Services The Jed Foundation exists to protect emotional health and prevent suicide for nation's teens and young adults. It develops expert resources and create partnerships. The firm educates and equip students, families and communities. The company was founded in 2000 and is headquartered in New York, NY. | Commercial Services |
Allergan Ltd. (Ireland)
 Allergan Ltd. (Ireland) Pharmaceuticals: MajorHealth Technology Allergan Plc engages in the research, development, and manufacture of pharmaceutical products. It operates through the following business segments: US Specialized Therapeutics; US General Medicine, and International. The US Specialized Therapeutics segment includes sales and expenses relating to branded products within the United States. The US General Medicine segment involves Central Nervous System; Gastrointestinal; Women's Health; Anti-Infectives; and Diversified brands. The International segment comprises of products sold outside the United States. The company was founded in 1982 and is headquartered in Dublin, Ireland. | Health Technology |
Karuna Therapeutics, Inc.
 Karuna Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Karuna Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company. engages in business of research and development of therapies utilizing muscarinic cholinergic receptors to treat psychosis and cognitive impairment in numerous central nervous system disorders. The company was founded by Andrew Miller, Eric Elenko, and Peter Jeffrey Conn in July 2009 and is headquartered in Boston, MA. | Health Technology |
| Allergan Foundation | |
Hildred Capital Management LLC
Hildred Capital Management LLC Investment ManagersFinance Hildred Capital Management LLC (Hildred Capital) is a private equity firm founded in 2014 by David Solomon and Andrew Goldman. The firm is headquartered in New York. | Finance |
Anthos Therapeutics, Inc.
Anthos Therapeutics, Inc. Pharmaceuticals: OtherHealth Technology Anthos Therapeutics, Inc. operates as a clinical-stage biopharmaceutical company that develops and commercializes innovative therapies for high-risk cardiovascular patients. It offers MAA868, an antibody directed at Factor XI and XIa, key components of the intrinsic coagulation pathway. The company was founded by Paris Panayiotopoulos, Ari Brettman and Jonathan E. Freeman in 2018 and is headquartered in Cambridge, MA. | Health Technology |
